Health Care·Pharmaceuticals·$2.2B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.39 | N/A | N/A |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.39 | N/A | N/A |
| Revenue | N/A | N/A | N/A |
Tone: Neutral
Management maintained a neutral tone during the call, emphasizing stability in operations. There was no specific guidance offered for future performance.
Management did not provide specific guidance for future quarters.
The call focused on maintaining current operations and market positioning.
Phibro Animal Health's earnings report showed an EPS of $0.39, but no revenue figures were disclosed. The stock reacted positively, rising 2.11%, likely due to the EPS figure meeting expectations despite the lack of revenue data. Investors may be optimistic about the company's operational stability.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
VISTRA CORP
May 3, 2019